1. Home
  2. VTAK vs SCNI Comparison

VTAK vs SCNI Comparison

Compare VTAK & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$0.15

Market Cap

1.8M

Sector

Health Care

ML Signal

HOLD

Logo Scinai Immunotherapeutics Ltd.

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$1.57

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTAK
SCNI
Founded
2002
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
1.7M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
VTAK
SCNI
Price
$0.15
$1.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
938.1K
1.2M
Earning Date
08-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
89.53
50.00
EPS
N/A
N/A
Revenue
$442,000.00
N/A
Revenue This Year
$1,170.33
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3057.14
N/A
52 Week Low
$0.15
$0.21
52 Week High
$3.20
$3.58

Technical Indicators

Market Signals
Indicator
VTAK
SCNI
Relative Strength Index (RSI) 28.15 49.80
Support Level N/A $0.36
Resistance Level $0.21 $3.58
Average True Range (ATR) 0.01 0.21
MACD 0.01 -0.13
Stochastic Oscillator 10.03 12.60

Price Performance

Historical Comparison
VTAK
SCNI

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.

Share on Social Networks: